"Risk Adjustment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The use of severity-of-illness measures, such as age, to estimate the risk (measurable or predictable chance of loss, injury or death) to which a patient is subject before receiving some health care intervention. This adjustment allows comparison of performance and quality across organizations, practitioners, and communities. (from JCAHO, Lexikon, 1994)
| Descriptor ID |
D020379
|
| MeSH Number(s) |
N04.452.871.715.800 N04.761.789.800 N05.715.360.750.625.700.690.800
|
| Concept/Terms |
Risk Adjustment- Risk Adjustment
- Adjustment, Risk
- Adjustments, Risk
- Risk Adjustments
Case-Mix Adjustment- Case-Mix Adjustment
- Adjustment, Case-Mix
- Adjustments, Case-Mix
- Case Mix Adjustment
- Case-Mix Adjustments
|
Below are MeSH descriptors whose meaning is more general than "Risk Adjustment".
Below are MeSH descriptors whose meaning is more specific than "Risk Adjustment".
This graph shows the total number of publications written about "Risk Adjustment" by people in this website by year, and whether "Risk Adjustment" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 2 | 3 |
| 2006 | 2 | 0 | 2 |
| 2007 | 2 | 2 | 4 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 1 | 2 |
| 2013 | 2 | 3 | 5 |
| 2014 | 1 | 3 | 4 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 3 | 4 |
| 2017 | 1 | 6 | 7 |
| 2018 | 1 | 1 | 2 |
| 2020 | 4 | 5 | 9 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Risk Adjustment" by people in Profiles.
-
Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma. Blood Adv. 2023 06 13; 7(11):2494-2495.
-
Public reporting for coronary artery bypass graft surgery: The quest for the optimal scorecard. J Thorac Cardiovasc Surg. 2023 09; 166(3):805-815.e1.
-
Comparative Effectiveness of Risk-adjusted Cumulative Sum and Periodic Evaluation for Monitoring Hospital Perioperative Mortality. Med Care. 2021 07 01; 59(7):639-645.
-
Comparison of management strategies for neonates with symptomatic tetralogy of Fallot and weight <2.5?kg. J Thorac Cardiovasc Surg. 2022 01; 163(1):192-207.e3.
-
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020 12 22; 76(25):3022-3055.
-
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020 12 22; 76(25):e159-e240.
-
Pregnancy in Women with Adult Congenital Heart Disease. Cardiol Clin. 2021 Feb; 39(1):55-65.
-
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program. Am J Kidney Dis. 2021 01; 77(1):23-34.e1.
-
Risk-adjustment models in patients undergoing head and neck surgery with reconstruction. Oral Oncol. 2020 12; 111:104917.
-
Diagnostic Imaging and Outcomes for Nonobstetric Surgery During Pregnancy. Clin Obstet Gynecol. 2020 06; 63(2):364-369.